Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Aster DM Quality Care Ltd (ASTERDM) Share Price & Fundamentals

Company Overview

Founded Year

1987

Listed Year

2018

Headquarter

Hyderabad, India

MD/CEO

-

Website

https://www.asterdmhealthcare.in

Company Facts

What we do

Aster DM Healthcare is an integrated healthcare services provider operating hospitals, clinics, labs, and pharmacies, delivering primary to quaternary care in India and GCC.

Founded in

1,987

Market share

Among top healthcare players in South India and GCC, with extensive hospital and clinic networks and strong market growth through merger with Quality Care India.

Problem solved

Provides accessible, affordable, and comprehensive healthcare services to diverse populations addressing healthcare infrastructure gaps.

Top clients or who we serve

Serving patients across India and GCC including individuals, insurers, and government health schemes; B2C and B2B focus via hospitals, labs, and pharmacies.

Key management

-

Our journey and innovations

Founded by Dr. Azad Moopen in 1987, expanded from a single clinic to a vast network through acquisitions, innovations like telemedicine and high-end surgical technologies.

Where we operate

India (Kerala, Karnataka, Andhra Pradesh, Telangana, Maharashtra) and GCC region, with a growing footprint post GCC business segregation.

Top products or what we offer

Hospitals, clinics, retail pharmacies, diagnostic labs, digital health services, medical education; flagship brands include Aster, MIMS, Ramesh, and Prime.

Top brands

Aster Hospitals (#1 in South India), MIMS, Ramesh Hospitals; Aster Pharmacy with rapidly expanding retail presence; Aster Labs with extensive diagnostics.

Raw materials needed

Pharmaceutical products, medical supplies, diagnostics equipment required for healthcare services.

Raw materials supplier

Major global and local pharmaceutical and medical supply companies; alliances with healthcare technology providers.

Recurring vs cyclical contribution

Revenue mix includes recurring income from hospital services, outpatient visits, pharmacy sales, with cyclical elements in elective procedures.

Our industry position

Top 3 hospital chains in India by bed capacity and revenue after merger; strong presence in South and Central India with high occupancy and ARPOB.

Financial highlights

Consolidated revenue INR 4,287 Cr and net profit INR 5,378 Cr for FY25; operating EBITDA margin ~20%; strong growth driven by organic expansion and merger synergies.

Geographical revenue split

Revenue mainly from India (36%) and previously GCC (major business divested in 2024). Post-merger footprint expanded across 9 states and 28 cities in India.

Order book

Ongoing expansions include new hospitals and additional capacity in key clusters with ~1,684 greenfield and 684 brownfield beds planned.

Whats driving growth

Growth driven by merger with Quality Care India, expansion of bed capacity, digital health services, higher case-mix with specialty care, and operational efficiencies.

Our future plans

Capex focused on greenfield and brownfield expansions in Kerala, Karnataka, Telangana; integration of merged entity; digital platform growth; improving operational metrics.

Our green promise

Implemented renewable energy including solar and wind at key hospitals, water recycling, waste reduction, and sustainability-driven infrastructure development.

Our people and values

Over 16,400 employees standalone; culture emphasizing integrity, compassion, excellence, respect, unity, with gender diversity including ~25% women on board.

Key challenges ahead

Integration of merged entities, competition, regulatory compliance, healthcare workforce retention, and managing costs amid expansion.

Interesting facts

First Indian hospital with intraoperative electron radiation therapy; pioneer in telemedicine in UAE; employs India’s first robotic surgical systems; extensive CSR initiatives.

Risks and strategy

Mitigates risks via diversified geography and services, strong governance, digital adoption, and focus on quality to counter competitive and regulatory challenges.

Market Footprint

Top Clients

Top Clients

Serving patients across India and GCC including individuals, insurers, and government health schemes; B2C and B2B focus via hospitals, labs, and pharmacies.

Top Products

Top Products

Hospitals, clinics, retail pharmacies, diagnostic labs, digital health services, medical education; flagship brands include Aster, MIMS, Ramesh, and Prime.

Price Movement & Share Holding

Today's High/Low

669683

52 Week High/Low

519.1891.3
Past Returns

1 week

2.97%

1 month

-10.42%

3 month

-17.71%

1 year

-4.4%

3 year

101.58%

5 year

264.52%

Share Holding

Promoters

53.79%

FII

8.18%

DII

21.67%

Retail

8.58%

Others

7.79%

Company Overview

Founded Year

1987

Listed Year

2018

Headquarter

Hyderabad, India

MD/CEO

-

Website

https://www.asterdmhealthcare.in

Price Movement & Share Holding

Today's High/Low

669683

52 Week High/Low

519.1891.3

Past Returns

1 week

2.97%

1 month

-10.42%

3 month

-17.71%

1 year

-4.4%

3 year

101.58%

5 year

264.52%

Share Holding

Promoters

53.79%

FII

8.18%

DII

21.67%

Retail

8.58%

Others

7.79%

Company Facts

What we do

Aster DM Healthcare is an integrated healthcare services provider operating hospitals, clinics, labs, and pharmacies, delivering primary to quaternary care in India and GCC.

Founded in

1987

Market share

Among top healthcare players in South India and GCC, with extensive hospital and clinic networks and strong market growth through merger with Quality Care India.

Problem solved

Provides accessible, affordable, and comprehensive healthcare services to diverse populations addressing healthcare infrastructure gaps.

Top clients or who we serve

Serving patients across India and GCC including individuals, insurers, and government health schemes; B2C and B2B focus via hospitals, labs, and pharmacies.

Our journey and innovations

Founded by Dr. Azad Moopen in 1987, expanded from a single clinic to a vast network through acquisitions, innovations like telemedicine and high-end surgical technologies.

Where we operate

India (Kerala, Karnataka, Andhra Pradesh, Telangana, Maharashtra) and GCC region, with a growing footprint post GCC business segregation.

Top products or what we offer

Hospitals, clinics, retail pharmacies, diagnostic labs, digital health services, medical education; flagship brands include Aster, MIMS, Ramesh, and Prime.

Top brands

Aster Hospitals (#1 in South India), MIMS, Ramesh Hospitals; Aster Pharmacy with rapidly expanding retail presence; Aster Labs with extensive diagnostics.

Raw materials needed

Pharmaceutical products, medical supplies, diagnostics equipment required for healthcare services.

Raw materials supplier

Major global and local pharmaceutical and medical supply companies; alliances with healthcare technology providers.

Recurring vs cyclical contribution

Revenue mix includes recurring income from hospital services, outpatient visits, pharmacy sales, with cyclical elements in elective procedures.

Our industry position

Top 3 hospital chains in India by bed capacity and revenue after merger; strong presence in South and Central India with high occupancy and ARPOB.

Financial highlights

Consolidated revenue INR 4,287 Cr and net profit INR 5,378 Cr for FY25; operating EBITDA margin ~20%; strong growth driven by organic expansion and merger synergies.

Geographical revenue split

Revenue mainly from India (36%) and previously GCC (major business divested in 2024). Post-merger footprint expanded across 9 states and 28 cities in India.

Order book

Ongoing expansions include new hospitals and additional capacity in key clusters with ~1,684 greenfield and 684 brownfield beds planned.

Whats driving growth

Growth driven by merger with Quality Care India, expansion of bed capacity, digital health services, higher case-mix with specialty care, and operational efficiencies.

Our future plans

Capex focused on greenfield and brownfield expansions in Kerala, Karnataka, Telangana; integration of merged entity; digital platform growth; improving operational metrics.

Our green promise

Implemented renewable energy including solar and wind at key hospitals, water recycling, waste reduction, and sustainability-driven infrastructure development.

Our people and values

Over 16,400 employees standalone; culture emphasizing integrity, compassion, excellence, respect, unity, with gender diversity including ~25% women on board.

Key challenges ahead

Integration of merged entities, competition, regulatory compliance, healthcare workforce retention, and managing costs amid expansion.

Interesting facts

First Indian hospital with intraoperative electron radiation therapy; pioneer in telemedicine in UAE; employs India’s first robotic surgical systems; extensive CSR initiatives.

Risks and strategy

Mitigates risks via diversified geography and services, strong governance, digital adoption, and focus on quality to counter competitive and regulatory challenges.

Market Footprint

Top Clients

Top Clients

Serving patients across India and GCC including individuals, insurers, and government health schemes; B2C and B2B focus via hospitals, labs, and pharmacies.

Top Products

Top Products

Hospitals, clinics, retail pharmacies, diagnostic labs, digital health services, medical education; flagship brands include Aster, MIMS, Ramesh, and Prime.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions